[1]
Meiffren G, Herbrand T, Anastassiadis E, Klein O, DeVries JH, Heise T, Alluis B, Mégret C, Gaudier M, Soula O, Plum-Mörschel L. Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes. Diabetes, obesity & metabolism. 2019 Jul:21(7):1570-1575. doi: 10.1111/dom.13685. Epub 2019 Apr 8
[PubMed PMID: 30828929]
[2]
Sharma AK, Taneja G, Kumar A, Sahu M, Sharma G, Kumar A, Sardana S, Deep A. Insulin analogs: Glimpse on contemporary facts and future prospective. Life sciences. 2019 Feb 15:219():90-99. doi: 10.1016/j.lfs.2019.01.011. Epub 2019 Jan 10
[PubMed PMID: 30639280]
[3]
Melo KFS, Bahia LR, Pasinato B, Porfirio GJM, Martimbianco AL, Riera R, Calliari LEP, Minicucci WJ, Turatti LAA, Pedrosa HC, Schaan BD. Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetology & metabolic syndrome. 2019:11():2. doi: 10.1186/s13098-018-0397-3. Epub 2019 Jan 3
[PubMed PMID: 30622653]
Level 1 (high-level) evidence
[4]
Schloot NC, Hood RC, Corrigan SM, Panek RL, Heise T. Concentrated insulins in current clinical practice. Diabetes research and clinical practice. 2019 Feb:148():93-101. doi: 10.1016/j.diabres.2018.12.007. Epub 2018 Dec 21
[PubMed PMID: 30583034]
[5]
Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Donnor T, Sarkar S. Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy. Endotext. 2000:():
[PubMed PMID: 25905175]
[6]
Wong EY, Kroon L. Ultra-Rapid-Acting Insulins: How Fast Is Really Needed? Clinical diabetes : a publication of the American Diabetes Association. 2021 Oct:39(4):415-423. doi: 10.2337/cd20-0119. Epub
[PubMed PMID: 34866783]
[7]
Heinemann L, Beals JM, Malone J, Anderson J, Jacobson JG, Sinha V, Corrigan SM. Concentrated insulins: History and critical reappraisal. Journal of diabetes. 2019 Apr:11(4):292-300. doi: 10.1111/1753-0407.12861. Epub 2018 Nov 13
[PubMed PMID: 30264527]
[8]
American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes care. 2022 Jan 1:45(Suppl 1):S125-S143. doi: 10.2337/dc22-S009. Epub
[PubMed PMID: 34964831]
[9]
Madenidou AV, Paschos P, Karagiannis T, Katsoula A, Athanasiadou E, Kitsios K, Bekiari E, Matthews DR, Tsapas A. Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Annals of internal medicine. 2018 Aug 7:169(3):165-174. doi: 10.7326/M18-0443. Epub 2018 Jul 10
[PubMed PMID: 29987326]
Level 2 (mid-level) evidence
[10]
American Diabetes Association. 11. Older Adults: Standards of Medical Care in Diabetes-2018. Diabetes care. 2018 Jan:41(Suppl 1):S119-S125. doi: 10.2337/dc18-S011. Epub
[PubMed PMID: 29222382]
[11]
Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ, Barzilay JI, Blonde L, Bush MA, DeFronzo RA, Garber JR, Garvey WT, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Perreault L, Rosenblit PD, Samson S, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2020 Jan:26(1):107-139. doi: 10.4158/CS-2019-0472. Epub
[PubMed PMID: 32022600]
Level 3 (low-level) evidence
[12]
Chun J, Strong J, Urquhart S. Insulin Initiation and Titration in Patients With Type 2 Diabetes. Diabetes spectrum : a publication of the American Diabetes Association. 2019 May:32(2):104-111. doi: 10.2337/ds18-0005. Epub
[PubMed PMID: 31168280]
[13]
. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstetrics and gynecology. 2018 Feb:131(2):e49-e64. doi: 10.1097/AOG.0000000000002501. Epub
[PubMed PMID: 29370047]
[14]
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstetrics and gynecology. 2018 Dec:132(6):e228-e248. doi: 10.1097/AOG.0000000000002960. Epub
[PubMed PMID: 30461693]
[15]
American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes care. 2022 Jan 1:45(Suppl 1):S232-S243. doi: 10.2337/dc22-S015. Epub
[PubMed PMID: 34964864]
[17]
By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023 Jul:71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4
[PubMed PMID: 37139824]
[18]
Toledano Y, Hadar E, Hod M. Pharmacotherapy for hyperglycemia in pregnancy - The new insulins. Diabetes research and clinical practice. 2018 Nov:145():59-66. doi: 10.1016/j.diabres.2018.04.035. Epub 2018 May 3
[PubMed PMID: 29730391]
[19]
Racsa PN, Meah Y, Ellis JJ, Saverno KR. Comparative Effectiveness of Rapid-Acting Insulins in Adults with Diabetes. Journal of managed care & specialty pharmacy. 2017 Mar:23(3):291-298. doi: 10.18553/jmcp.2017.23.3.291. Epub
[PubMed PMID: 28230457]
Level 2 (mid-level) evidence
[20]
Biagetti B, Corcoy R. Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes. World journal of clinical cases. 2013 Aug 16:1(5):169-71. doi: 10.12998/wjcc.v1.i5.169. Epub
[PubMed PMID: 24303494]
Level 3 (low-level) evidence
[21]
Lieberman JA 3rd. Metabolic changes associated with antipsychotic use. Primary care companion to the Journal of clinical psychiatry. 2004:6(Suppl 2):8-13
[PubMed PMID: 16001095]
[22]
Lagathu C, Béréziat V, Gorwood J, Fellahi S, Bastard JP, Vigouroux C, Boccara F, Capeau J. Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment. Expert opinion on drug safety. 2019 Sep:18(9):829-840. doi: 10.1080/14740338.2019.1644317. Epub 2019 Jul 19
[PubMed PMID: 31304808]
Level 3 (low-level) evidence
[23]
Tosur M, Viau-Colindres J, Astudillo M, Redondo MJ, Lyons SK. Medication-induced hyperglycemia: pediatric perspective. BMJ open diabetes research & care. 2020 Jan:8(1):. doi: 10.1136/bmjdrc-2019-000801. Epub
[PubMed PMID: 31958298]
Level 3 (low-level) evidence
[24]
Dungan K, Merrill J, Long C, Binkley P. Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovascular diabetology. 2019 Nov 27:18(1):163. doi: 10.1186/s12933-019-0967-1. Epub 2019 Nov 27
[PubMed PMID: 31775749]
[25]
Huang C, Banerjee K, Sochett E, Perlman K, Wherrett D, Daneman D. Hypoglycemia associated with clonidine testing for growth hormone deficiency. The Journal of pediatrics. 2001 Aug:139(2):323-4
[PubMed PMID: 11487765]
[26]
Shen J, Greenberg BH. Diabetes Management in Patients with Heart Failure. Diabetes & metabolism journal. 2021 Mar:45(2):158-172. doi: 10.4093/dmj.2020.0296. Epub 2021 Mar 25
[PubMed PMID: 33813814]
[27]
Wang C, Ding ZY, Shu SQ, Liu Y, Chen YC, Ran XW, An ZM, Tian HM, Tong NW, Li XJ, Yu YR. Severe insulin allergy after percutaneous transluminal coronary angioplasty. Clinical therapeutics. 2009 Mar:31(3):569-74. doi: 10.1016/j.clinthera.2009.03.014. Epub
[PubMed PMID: 19393846]
[28]
Hakre S, Upshaw-Combs DR, Sanders-Buell EE, Scoville SL, Kuper JD, Jagodzinski LL, Bradfield AN, Davison DC, Callis WG, Owens AB, Michael NL, O'Connell RJ, Peel SA, Gardner JW, Thompson ND, Hu DJ, Kim JH, Tovanabutra S, Scott PT, LaFon SG, Insulin Pen Investigation Team. An investigation of bloodborne pathogen transmission due to multipatient sharing of insulin pens. Military medicine. 2012 Aug:177(8):930-8
[PubMed PMID: 22934373]
[29]
Kjærulff MLBG, Astrup BS. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data. Journal of forensic and legal medicine. 2019 Apr:63():34-39. doi: 10.1016/j.jflm.2019.02.013. Epub 2019 Feb 26
[PubMed PMID: 30856551]
[30]
Malecki MT, Cao D, Liu R, Hardy T, Bode B, Bergenstal RM, Bue-Valleskey J. Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy. Diabetes technology & therapeutics. 2020 Nov:22(11):853-860. doi: 10.1089/dia.2020.0129. Epub 2020 Jun 10
[PubMed PMID: 32453647]
[31]
American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes care. 2022 Jan 1:45(Suppl 1):S97-S112. doi: 10.2337/dc22-S007. Epub
[PubMed PMID: 34964871]
[32]
Demirbilek H, Vuralli D, Haris B, Hussain K. Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies. Diabetes, metabolic syndrome and obesity : targets and therapy. 2023:16():259-273. doi: 10.2147/DMSO.S313837. Epub 2023 Jan 27
[PubMed PMID: 36760580]